加兰他敏对患有精神分裂症的吸烟者和非吸烟者认知缺陷的影响。 - Suppr

Effects of galantamine on cognitive deficits in smokers and non-smokers with schizophrenia.

作者信息

Sacco Kristi A, Creeden Cerissa, Reutenauer Erin L, George Tony P

出版信息

Schizophr Res. 2008 Aug;103(1-3):326-7. doi: 10.1016/j.schres.2008.05.004. Epub 2008 Jun 20.

DOI:10.1016/j.schres.2008.05.004

PMID:18571377

Abstract

摘要

相似文献

Effects of galantamine on cognitive deficits in smokers and non-smokers with schizophrenia.

Schizophr Res. 2008 Aug;103(1-3):326-7. doi: 10.1016/j.schres.2008.05.004. Epub 2008 Jun 20.

Effects of atomoxetine on cognitive function and cigarette smoking in schizophrenia.

Schizophr Res. 2009 Feb;107(2-3):332-3. doi: 10.1016/j.schres.2008.09.026. Epub 2008 Nov 7.

Galantamine for the treatment of cognitive impairments in people with schizophrenia.

Am J Psychiatry. 2008 Jan;165(1):82-9. doi: 10.1176/appi.ajp.2007.07050724. Epub 2007 Nov 6.

High-dose galantamine augmentation inferior to placebo on attention, inhibitory control and working memory performance in nonsmokers with schizophrenia.

Schizophr Res. 2008 Jul;102(1-3):88-95. doi: 10.1016/j.schres.2007.12.491. Epub 2008 Mar 5.

The effect of galantamine added to clozapine on cognition of five patients with schizophrenia.

Clin Neuropharmacol. 2005 May-Jun;28(3):139-41. doi: 10.1097/01.wnf.0000162555.68729.04.

Lack of beneficial galantamine effect for smoking behavior: a double-blind randomized trial in people with schizophrenia.

Schizophr Res. 2008 Aug;103(1-3):161-8. doi: 10.1016/j.schres.2008.04.027. Epub 2008 Jun 11.

Prefrontal cognitive dysfunction is associated with tobacco dependence treatment failure in smokers with schizophrenia.

Drug Alcohol Depend. 2009 Sep 1;104(1-2):94-9. doi: 10.1016/j.drugalcdep.2009.04.005. Epub 2009 May 17.

Schizophrenia with obsessive-compulsive disorder and obsessive-compulsive disorder with poor insight: a neuropsychological comparison.

Psychiatry Res. 2009 Jan 30;165(1-2):38-46. doi: 10.1016/j.psychres.2007.07.031. Epub 2008 Nov 7.

Cognitive impairment of executive function as a core symptom of schizophrenia.

World J Biol Psychiatry. 2009;10(4 Pt 2):442-51. doi: 10.1080/15622970701849986.

Does the ability to sustain attention underlie symptom severity in schizophrenia?

Schizophr Res. 2009 Feb;107(2-3):319-23. doi: 10.1016/j.schres.2008.07.013. Epub 2008 Sep 3.

引用本文的文献

Cholinergic Functioning, Cognition, and Anticholinergic Medication Burden in Schizophrenia.

Curr Top Behav Neurosci. 2023;63:393-406. doi: 10.1007/7854_2022_400.

Anti-Dementia Drugs for Psychopathology and Cognitive Impairment in Schizophrenia: A Systematic Review and Meta-Analysis.

Int J Neuropsychopharmacol. 2018 Aug 1;21(8):748-757. doi: 10.1093/ijnp/pyy045.

Medications Used for Cognitive Enhancement in Patients With Schizophrenia, Bipolar Disorder, Alzheimer's Disease, and Parkinson's Disease.

Front Psychiatry. 2018 Apr 4;9:91. doi: 10.3389/fpsyt.2018.00091. eCollection 2018.

Assessing the synergy between cholinomimetics and memantine as augmentation therapy in cognitive impairment in schizophrenia. A virtual human patient trial using quantitative systems pharmacology.

Front Pharmacol. 2015 Sep 22;6:198. doi: 10.3389/fphar.2015.00198. eCollection 2015.

Going up in smoke? A review of nAChRs-based treatment strategies for improving cognition in schizophrenia.

Curr Pharm Des. 2014;20(31):5077-92. doi: 10.2174/1381612819666131216121019.

Neurocognitive endophenotypes in schizophrenia: modulation by nicotinic receptor systems.

Prog Neuropsychopharmacol Biol Psychiatry. 2014 Jul 3;52:79-85. doi: 10.1016/j.pnpbp.2013.07.010. Epub 2013 Jul 19.

Donepezil, an acetylcholinesterase inhibitor, attenuates nicotine self-administration and reinstatement of nicotine seeking in rats.

Addict Biol. 2014 Jul;19(4):539-51. doi: 10.1111/adb.12014. Epub 2012 Dec 12.

Cognitive effects of the acetylcholinesterase inhibitor, donepezil, in healthy, non-treatment seeking smokers: a pilot feasibility study.

Drug Alcohol Depend. 2012 Nov 1;126(1-2):263-7. doi: 10.1016/j.drugalcdep.2012.04.019. Epub 2012 May 15.

Mouse pharmacological models of cognitive disruption relevant to schizophrenia.

Neuropharmacology. 2012 Mar;62(3):1381-90. doi: 10.1016/j.neuropharm.2011.06.013. Epub 2011 Jun 29.

Neuropsychological performance in patients with schizophrenia and controls as a function of cigarette smoking status.

Psychiatry Res. 2011 Aug 15;188(3):320-6. doi: 10.1016/j.psychres.2011.05.037. Epub 2011 Jun 12.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

Effects of galantamine on cognitive deficits in smokers and non-smokers with schizophrenia.

作者信息

出版信息

相似文献

引用本文的文献

文献AI研究员

用中文搜PubMed

文档翻译

Suppr 超能文献

相似文献

引用本文的文献